Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS FDA considers adding a dozen peptides to its bulk drug compounding list RAPS